Beijing Hotgen Biotech Co.Ltd(688068) issue the annual report and the first quarterly report. In 2021, the company realized an operating revenue of 53692038 million yuan, an increase of 945.54% year-on-year; The net profit attributable to the owners of the parent company was 21857634 million yuan, an increase of 185041% year-on-year. The basic earnings per share is 35.14 yuan. The company plans to distribute a cash dividend of 50 yuan (including tax) for every 10 shares, and convert the capital reserve into 4.8 shares for every 10 shares.
In the first quarter of 2022, the net profit was 606 million yuan, a year-on-year increase of 0.77%. The basic earnings per share is 9.74 yuan.
